ArticleBMC cancer2026

Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancers.

Muhammad Alaa Eldeen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.